Advertisement

Patientenselektion

  • K. Höfner

Zusammenfassung

In den 90er Jahren ist es zu einer immensen Zunahme verschiedener Behandlungsoptionen für Patienten mit benigner Prostatahyperplasie gekommen. Diese Veränderung betrifft sowohl konservative als auch instrumentell operative Therapieverfahren. Im Bereich der Medikamente wird vor allem der deutsche Markt nicht mehr allein von Phytotherapeutika beherrscht, sondern die Therapie mit selektiven und subselektiven Alphablockern und dem 5-Alpha-Reduktasehemmer Finasterid hat an Bedeutung zugenommen. Die operative Therapie der benignen Prostatahyperplasie, die noch bis in die 80er Jahre fast ausschließlich durch die transurethrale Resektion (TURP) bzw. die offene Enukleation beherrscht wurde, wird durch eine zunehmende Anzahl alternativer, instrumenteller Behandlungsverfahren wie transurethrale Mikrowellenthermotherapie (TUMT), transurethrale Nadelablation (TUNA), verschiedene Laserverfahren, hochfokussierten Ultraschall (HIFU) und Techniken der Elektrovaporisation verdrängt.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Abrams P (1995) Objective evaluation of bladder outlet obstruction. Br J Urol 76 [Suppl 1]:11–15PubMedGoogle Scholar
  2. 2.
    Abrams P (1997) Urodynamic effects of doxazosin in men with lower urinary tract symptoms and benign prostatic obstruction Results from three double-blind placebo-controlled studies. Eur Urol 32: 39–46PubMedGoogle Scholar
  3. 3.
    Abrams PH (1977) Prostatism and prostatectomy: the value of urine flow measurement in the preoperative assessment for operation. J Urol 117:70–71PubMedGoogle Scholar
  4. 4.
    Abrams PH, Dunn M, George NJR (1979) Urodynamic findings in chronic retention of urine and their relevance to results of surgery. BMJ 2:1258–1260CrossRefGoogle Scholar
  5. 5.
    Abrams PH, Farrar DJ, Turner WR, Whiteside CG, Feneley RC (1979) The results of prostatectomy: a symptomatic and urodynamic analysis of 152 patients. J Urol 121:640–642PubMedGoogle Scholar
  6. 6.
    Abrams PH, Griffiths DJ (1979) The assessment of prostatic obstruction from urodynamic measurement and from residual urine. Brit J Urol 51:129–134PubMedCrossRefGoogle Scholar
  7. 7.
    Ahmed M, Bell T, Lawrence WT, Ward JP, Watson GM (1997) Transurethral microwave thermotherapy (Prostatron version 2.5) compared with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: a randomized, controlled, parallel study. Br J Urol 79: 181–185PubMedGoogle Scholar
  8. 8.
    Ameda K, Koyanagi T, Nantani M, Taniguchi K, Matsuno T (1994) The relevance of preoperative cystometrography in patients with benign prostatic hyperplasia: correlating the findings with clinical features and outcome after prostatectomy. J Urol 152:443–447PubMedGoogle Scholar
  9. 9.
    Andersen JT (1982) Prostatism: clinical, radiological and urodynamic aspects. Neurourol Urodyn 1:241–293CrossRefGoogle Scholar
  10. 10.
    Andersen JT, Ekman P, Wölf H et al. (1995) Can finasteride reverse the progress of benign prostatic hyperplasia? A two-year placebo-controlled study. The Scandinavian BPH Study Group.Urology 46: 631–637PubMedCrossRefGoogle Scholar
  11. 11.
    Andersen JT, Nordling J (1980) Prostatism. II. The correlation between cysto-urethroscopic, cystometric and urodynamic findings. Scand J Urol Nephrol 14:23–27PubMedCrossRefGoogle Scholar
  12. 12.
    Andersen JT, Nordling J, Walter S (1979) Prostatism. I. The correlation between symptoms, cystometric and urodynamic findings. Scand J Urol Nephrol 13:229–236PubMedCrossRefGoogle Scholar
  13. 13.
    Anderson JB, Grant JB (1991) Postoperative retention of urine: a prospective urodynamic study. BMJ 302: 894–896PubMedCrossRefGoogle Scholar
  14. 14.
    Anonym (1995) B.E.S.S. Data. Washington, DC: Health Care Financing AdministrationGoogle Scholar
  15. 15.
    Anson K, Nawrocki J, Buckley Jet al. (1995) A multicenter, randomized, prospective study of endoscopic laser ablation versus transurethral resection of the prostate. Urology 46: 305–310PubMedCrossRefGoogle Scholar
  16. 16.
    Baba S, Nakamura K, Tachibana M, Murai M (1996) Transurethral microwave thermotherapy for management of benign prostatic hyperplasia: durability of response. Urology 47:664–671PubMedCrossRefGoogle Scholar
  17. 17.
    Barry MJ, Cockett AT, Holtgrewe HL, McConnell JD, Sihelnik SA, Winfield HN (1993) Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urol 150:351–358PubMedGoogle Scholar
  18. 18.
    Bissada NK, Finkbeiner AE, Redman JF (1976) Accuracy of preoperative estimation of resection weight in transurethral prostatectomy. J Urol 116:201–202PubMedGoogle Scholar
  19. 19.
    Bosch JL (1997) Urodynamic effects of various treatment modalities for benign prostatic hyperplasia. J Urol 158:2034–2044PubMedCrossRefGoogle Scholar
  20. 20.
    Bosch JL, Hop WC, Kirkels WJ, Schröder FH (1995) The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. Br J Urol 75:622–630PubMedCrossRefGoogle Scholar
  21. 21.
    Bosch JL, Kranse R, van Mastrigt R, Schröder FH (1995) Reasons for the weak correlation between prostate volume and urethral resistance parameters in patients with prostatism. J Urol 153: 689–693PubMedCrossRefGoogle Scholar
  22. 22.
    Boyle P, Lawrence A, Roehrborn G (1996) Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: metaanalysis of randomized clinical trials. Urology 48: 398–405PubMedCrossRefGoogle Scholar
  23. 23.
    Bruskewitz R, Issa MM, Roehrborn CG, Naslund MJ, Perez-Marrero R, Shumaker BP, Oesterling JE (1998) A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia. J Urol 159:1588–1593PubMedCrossRefGoogle Scholar
  24. 24.
    Bruskewitz RC, Larsen EH, Madsen PO, Doerflinger T (1986) 3 year followup of urinary symptoms after transurethral resection of the prostate. J Urol 136: 613PubMedGoogle Scholar
  25. 25.
    Bruskewitz RC, Reda DJ, Wasson JH, Barrett L, Phelan M (1997) Testing to predict outcome after transurethral resection of the prostate. J Urol 157:1304–1308PubMedCrossRefGoogle Scholar
  26. 26.
    Chancellor MB, Blaivas JG, Kaplan SA, Axelrod S (1991) Bladder outlet obstruction versus impaired detrusor contractility: the role of outflow. J Urol 145: 810–812PubMedGoogle Scholar
  27. 27.
    Chapple CR, Carter P, Christmas TJ, Kirby RS, Bryan J, Milroy EJ, Abrams P (1994) A three month double-blind study of doxazosin as treatment for benign prostatic bladder outlet obstruction. Br J Urol 74: 50–56PubMedCrossRefGoogle Scholar
  28. 28.
    Chiou RK, Binard JE, Ebersole ME, Horan JJ, Chiou YK, Lynch B (1994) Randomized comparison of balloon dilation and transurethral incision for treatment of symptomatic benign prostatic hyperplasia. J Endourol 8: 221–224PubMedCrossRefGoogle Scholar
  29. 29.
    Cote RJ, Burke H, Schoenberg HW (1981) Prediction of unusual postoperative results by urodynamic testing in benign prostatic hyperplasia. J Urol 125:690–692PubMedGoogle Scholar
  30. 30.
    Cowles RS, Kabalin JN, Childs S, Lepor H, Dixon C, Stein B, Zabbo A (1995) A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia. Urology 46:155–160PubMedCrossRefGoogle Scholar
  31. 31.
    Cucchi A (1990) Acceleration of flow rate in obstructive detrusor instability. Br J Urol 66: 26–29PubMedCrossRefGoogle Scholar
  32. 32.
    Dahlstrand C, Geirsson G, Fall M, Pettersson S (1993) Transurethral microwave thermotherapy versus transurethral resection for benign prostatic hyperplasia: preliminary results of a randomized study. Eur Urol 23: 292–298PubMedGoogle Scholar
  33. 33.
    Dahlstrand C, Waiden M, Geirsson G, Pettersson S (1995) Transurethral microwave thermotherapy versus transurethral resection for symptomatic benign prostatic obstruction: a prospective randomized study with a 2-year follow-up. Br J Urol 76: 614–618PubMedCrossRefGoogle Scholar
  34. 34.
    d’Ancona FC, Francisca EA, Witjes WP, Welling L, Debruyne FM, de la Rosette JJ (1997) High energy thermotherapy versus transurethral resection in the treatment of benign prostatic hyperplasia: results of a prospective randomized study with 1 year of followup. J Urol 158:120–125PubMedCrossRefGoogle Scholar
  35. 35.
    de la Rosette JJ, de Wildt MJ, Höfner K, Carter SS, Debruyne FM, Tubaro A (1996) High energy thermotherapy in the treatment of benign prostatic hyperplasia: results of the European Benign Prostatic Hyperplasia Study Group. J Urol 156: 97–101PubMedCrossRefGoogle Scholar
  36. 36.
    de la Rosette JJ, Francisca EA, Carter SSC et al. (1997) Longterm follow up TUMT 2.0: a multicentre study. SIU, 24th World Congress Montreal. Brit J Urol 80 [Suppl 2]: 188.Google Scholar
  37. 37.
    de Wildt MJ, Tubaro A, Höfner K, Carter SS, de la Rosette JJ, Devonec M (1995) Responders and nonresponders to transurethral microwave thermotherapy: a multicenter retrospective analysis. J Urol 154: 1775–1778PubMedCrossRefGoogle Scholar
  38. 38.
    Debruyne FMJ, Jardin A, Colloi D et al. (1998) Sustained-realease alfuzosin, finasteride and the combination of both in the treatment of benign prostatic hyperplasia. Eur Urol 34:169–175PubMedCrossRefGoogle Scholar
  39. 39.
    Denis L, McConnell J, Yoshida O et al. (1998) 4th International Consultation on BPH. Recommendations of the International Scientific Committee: the evaluation and treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic obstruction. In: Denis L, Griffiths K, McConnell J, ChatelaIn C, Murphy G, Yoshida O(eds) 4th International Consultation on BPH, Paris 1997. Health Publication Ltd, Plymouth, 669–684Google Scholar
  40. 40.
    Doli HA, Black NA, McPherson K, Flood AB, Williams GB, Smith JC (1992) Mortality, morbidity and complications following transurethral resection of the prostate for benign prostatic hypertrophy. J Urol 147: 1566–1573Google Scholar
  41. 41.
    Dorflinger T, Bruskewitz R, Jensen KM, Iversen P, Madsen PO (1986) Predictive value of low maximum flow rate in benign prostatic hyperplasia. Urology 27: 569–573PubMedCrossRefGoogle Scholar
  42. 42.
    Dorflinger T, England DM, Madsen PO, Bruskewitz RC (1988) Urodynamic and histological correlates of benign prostatic hyperplasia. J Urol 140:1487–1490PubMedGoogle Scholar
  43. 43.
    Elbadawi A, Yalla SV, Resnick NM (1993) Structural basis of geriatric voiding dysfunction. I. Methods of a prospective ultrastructural/urodynamic study and an overview of the findings. J Urol 150:1650–1656PubMedGoogle Scholar
  44. 44.
    Elbadawi A, Yalla SV, Resnick NM (1993) Structural basis of geriatric voiding dysfunction. II. Aging detrusor: normal versus impaired contractility.J Urol 150:1657–1667PubMedGoogle Scholar
  45. 45.
    Elbadawi A, Yalla SV, Resnick NM (1993) Structural basis of geriatric voiding dysfunction. III. Detrusor overactivity.J Urol 150:1668–1680PubMedGoogle Scholar
  46. 46.
    Elbadawi A, Yalla SV, Resnick NM (1993) Structural basis of geriatric voiding dysfunction. IV. Bladder outlet obstruction.J Urol 150:1681–1695PubMedGoogle Scholar
  47. 47. Eliasson TU, Abramsson LB, Pettersson GT, Damber JE (1995) Responders and non-responders to treatment of benign prostatic hyperplasia with transurethral microwave thermotherapy. Scand J Urol Nephrol 29:183–191PubMedCrossRefGoogle Scholar
  48. 48.
    Ezz el Din K, Kiemeney LA, de Wildt MJ, Debruyne FM, de la Rosette JJ (1996) Correlation between uroflowmetry, prostate volume, postvoid residue, and lower urinary tract symptoms as measured by the International Prostate Symptom Score. Urology 48: 393–397PubMedCrossRefGoogle Scholar
  49. 49.
    Fowler FJ, Wennberg JE, Timothy RP (1988) Symptom status and quality of life following prostatectomy. JAMA 259: 3018–3022PubMedCrossRefGoogle Scholar
  50. 50.
    Frimodt MP, Jensen KM, Iversen P, Madsen PO, Bruskewitz RC (1984) Analysis of presenting symptoms in prostatism. J Urol 132:272–276Google Scholar
  51. 51.
    Gallucci M, Puppo P, Perachino M et al. (1998) Transurethral electrovaporization of the prostate vs. transurethral resection. Results of a multicentric, randomized clinical study on 150 patients. Eur Urol 33: 359–364PubMedCrossRefGoogle Scholar
  52. 52.
    George NJ, O’Reilly PH, Barnard RJ, Blacklock NJ (1983) High pressure chronic retention. Br Med J Clin Res Ed 286:1780–1783PubMedCrossRefGoogle Scholar
  53. 53.
    Gerber GS, Kim JH, Contreras BA, Steinberg GD, Rukstalis DB (1996) An observational urodynamic evaluation of men with lower urinary tract symptoms treated with doxazosin. Urology 47: 840–844PubMedCrossRefGoogle Scholar
  54. 54.
    Girman CJ, Jacobsen SJ, Guess HA, Oesterling JE, Chute CG, Panser LA, Lieber MM (1995) Natural history of prostatism: relationship among symptoms, prostate volume and peak urinary flow rate [see comments]. J Urol 153:1510–1515PubMedCrossRefGoogle Scholar
  55. 55.
    Gleason DM, Bottaccini MR (1994) Effect of terazosin on urine storage and voiding in the aging male with prostatism. Neurourol Urodyn 13:1–12PubMedCrossRefGoogle Scholar
  56. 56.
    Gleason DM, Bottaccini MR, Drach GW, Layton TN (1982) Urinary flow velocity as an index of male voiding function. J Urol 128:1363–1367PubMedGoogle Scholar
  57. 57.
    Griffiths D, Höfner K, van Mastrigt R, Rollema HJ, Spangberg A, Gleason D (1997) Standardization of terminology of lower urinary tract function: pressure-flow studies of voiding, urethral resistance, and urethral obstruction. International Continence Society Subcommittee on Standardization of Terminology of Pressure-Flow Studies. Neurourol Urodyn 16:1–18PubMedCrossRefGoogle Scholar
  58. 58.
    Hammadeh MY, Fowlis GA, Singh M, Philp T (1998) Transurethral electrovaporization of the prostate-a possible alternative to transurethral resection: a one-year follow-up of a prospective randomized trial. Br J Urol 81: 721–725PubMedGoogle Scholar
  59. 59.
    Höfner K, Tubaro A, de la Rosette JJ, Carter SS (1998) Analysis of outcome after thermotherapy using different classifications of bladder outlet obstruction. Neurourol Urodyn 17:109–120CrossRefGoogle Scholar
  60. 60.
    Holtgrewe HL, Bay-Nielsen H, Carlsson P et al. (1998) The economics of the management of lower urinary tract symptoms and benign prostatic hyperplasia. In: Denis L, Griffiths K, McConnell J, ChatelaIn C, Murphy G, Yoshida O (eds) 4th International Consultation on BPH, Paris 1997. Health Publication Ltd, Plymouth, 63–81Google Scholar
  61. 61.
    Holtgrewe HL, Valk WJ (1962) Factors influencing the mortality and morbidity of transurethral prostatectomy. J Urol 87:450–459PubMedGoogle Scholar
  62. 62.
    Homma Y, Imajo C, Takahashi S, Kawabe K, Aso Y (1994) Urinary symptoms and urodynamics in a normal elderly population. Scand J Urol Nephrol [Suppl] 157:27–30Google Scholar
  63. 63.
    Iversen P, Bruskewitz RC, Jensen KM, Madsen PO (1983) Transurethral prostatic resection in the treatment of prostatism with high urinary flow. J Urol 129: 995–997PubMedGoogle Scholar
  64. 64.
    Jacobsen SJ, Jacobson DJ, Girman CJ, Roberts RO, Rhodes T, Guess HA, Lieber MM (1997) Natural history of prostatism: risk factors for acute urinary retention. J Urol 158:481–487PubMedCrossRefGoogle Scholar
  65. 65.
    Jensen KM, Bruskewitz RC, Iversen P, Madsen PO (1983) Predictive value of voiding pressures in benign prostatic hyperplasia. Neurourol Urodyn 2:117–125CrossRefGoogle Scholar
  66. 66.
    Jensen KM, Bruskewitz RC, Iversen P, Madsen PO (1983) Significance of prostatic weight in prostatism. Urol Int 38:173–178PubMedCrossRefGoogle Scholar
  67. 67.
    Jensen KM, Bruskewitz RC, Iversen P, Madsen PO (1984) Spontaneous uroflowmetry in prostatism. Urology 24:403–409PubMedCrossRefGoogle Scholar
  68. 68.
    Jensen KM, Jorgensen JB, Mogensen P (1988) Urodynamics in prostatism. I. Prognostic value of uroflowmetry. Scand J Urol Nephrol 22:109–117PubMedGoogle Scholar
  69. 69.
    Jensen KM, Jorgensen JB, Mogensen P (1988) Urodynamics in prostatism. II. Prognostic value of pressure-flow study combined with stop-flow test. Scand J Urol Nephrol [Suppl] 114: 72–77Google Scholar
  70. 70.
    Jensen KM, Jorgensen JB, Mogensen P (1988) Urodynamics in prostatism. III. Prognostic value of medium-fill water cystometry. Scand J Urol Nephrol [Suppl] 114:78–83Google Scholar
  71. 71.
    Jensen KM, Jorgensen JB, Mogensen P (1988) Urodynamics in prostatism. IV. Search for prognostic patterns as evaluated by linear discriminant analysis. Scand J Urol Nephrol [Suppl] 114: 84–86Google Scholar
  72. 72.
    Jones KW, Schoenberg HW (1985) Comparison of the incidence of bladder hyperreflexia in patients with benign prostatic hypertrophy and age-matched female controls. J Urol 133:425–426PubMedGoogle Scholar
  73. 73.
    Jorgensen JB, Jensen KM, Mogensen P (1990) Significance of predominantly irritative symptomatology before a prostatic operation. J Urol 143: 739–741PubMedGoogle Scholar
  74. 74.
    Kabalin JN, Bite G, Doli S (1996) Neodymium:Yag laser coagulation prostatectomy: 3 years of experience with 227 patients. J Urol 155:181–185PubMedCrossRefGoogle Scholar
  75. 75.
    Kadow C, Feneley RC, Abrams PH (1988) Prostatectomy or conservative management in the treatment of benign prostatic hypertrophy?Br J Urol 61: 432–434PubMedCrossRefGoogle Scholar
  76. 76.
    Kaplan SA, Goluboff ET, Olsson CA, Deverka PA, Chmiel JJ (1995) Effect of demographic factors, urinary peak flow rates, and Boyarsky symptom scores on patient treatment choice in benign prostatic hyperplasia. Urology 45: 398–405PubMedCrossRefGoogle Scholar
  77. 77.
    Kaplan SA, Laor E, Fatal M, Te AE (1998) Transurethral resection of the prostate versus transurethral electrovaporization of the prostate: a blinded, prospective comparative study with 1-year followup. J Urol 159: 454–458PubMedCrossRefGoogle Scholar
  78. 78.
    Kaplan SA, Te AE, Pressler LB, Olsson CA (1995) Transition zone index as a method of assessing benign prostatic hyperplasia: correlation with symptoms, urine flow and detrusor pressure. J Urol 154:1764–1769PubMedCrossRefGoogle Scholar
  79. 79.
    Kirkland JL, Levy DW, Banerjee AK (1983) Patterns of urine flow and electrolyte excretion in healthy elderly people. Br Med J 287:1665–1667CrossRefGoogle Scholar
  80. 80.
    Ko DS, Fenster HN, Chambers K, Sullivan LD, Jens M, Goldenberg SL (1995) The correlation of multichannel urodynamic pressure-flow studies and American Urological Association symptom index in the evaluation of benign prostatic hyperplasia. J Urol 154: 396–398PubMedCrossRefGoogle Scholar
  81. 81.
    Koyanagi T, Ameda K, Nantani M, Taniguchi K, Matsuno T, Shinno Y (1995) Preoperative cystometrography in patients with clinical benign prostatic hypertrophy. World J Urol 13: 24–29PubMedCrossRefGoogle Scholar
  82. 82.
    Krah H, Höfner K, Tan HK, Jonas U (1995) The limitation of uroflow in BPH-patients with high and low Qmax-values. J Urol 153 [Suppl]: 275 A.Google Scholar
  83. 83.
    Krah H, Höfner K, Tan HK, Schäfer J, Hoffmann J, Jonas U (1995) The shape of the prostate in transrectal ultrasound is no parameter to quantify mechanical obstruction. Akt Urol 26 [Suppl]: 119–120CrossRefGoogle Scholar
  84. 84.
    Kupeli S, Baltaci S, Soygur T, Aytac S, Yilmaz E, Budak M (1998) A prospective randomized study of transurethral resection of the prostate and transurethral vaporization of the prostate as a therapeutic alternative in the management of men with BPH.Eur Urol 34:15–18PubMedCrossRefGoogle Scholar
  85. 85.
    Lepor H, Machi G (1993) Comparison of AUA symptom index in unselected males and females between fifty-five and seventy-nine years of age. Urology 42 :36–40PubMedCrossRefGoogle Scholar
  86. 86.
    Lepor H, Nieder A, Feser J, O’Connell C, Dixon C (1997) Total prostate and transition zone volumes, and transition zone index are poorly correlated with objective measures of clinical benign prostatic hyperplasia. J Urol 158: 85–88PubMedCrossRefGoogle Scholar
  87. 87.
    Lepor H, Williford WO, Barry MJ et al. (1996) The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group. N Engl J Med 335: 533–539Google Scholar
  88. 88.
    Lewis WH, Alving AS (1938) Changes with age in the renal function of adult men. Am J Physiol 153:500–515Google Scholar
  89. 89.
    Manoliu RA (1987) Voiding cystourethrography with synchronous measurements of pressures and flow in the diagnosis of subvesical obstruction in men: a radiological view. J Urol 137: 1196–1201PubMedGoogle Scholar
  90. 90.
    McConnell JD (1994) Why pressure-flow studies should be optional and not mandatory studies for evaluating men with benign prostatic hyperplasia [editorial]. Urology 44:156–158PubMedCrossRefGoogle Scholar
  91. 91.
    McConnell JD, Barry MJ, Bruskewitz RC et al. (1994) Direct treatment outcomes: complications, sexual dysfunction, urinary incontinence, late complications benign prostatic hyperplasia: diagnosis and treatment. Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services, Rockville, MD, 91-110Google Scholar
  92. 92.
    McConnell JD, Barry MJ, Bruskewitz RC et al. (1994) Direct treatment outcomes: need for retreatment benign prostatic hyperplasia: diagnosis and treatment. Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services, Rockville, MD, 111-120Google Scholar
  93. 93.
    McConnell JD, Barry MJ, Bruskewitz RC et al. (1994) Direct treatment outcomes-symptom improvement benign prostatic hyperplasia: diagnosis and treatment. Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services, Rockville, MD, 83-89Google Scholar
  94. 94.
    McConnell JD, Barry MJ, Bruskewitz RC et al. (1994) Tests not recommended benign prostatic hyperplasia: diagnosis and treatment. Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services, Rockville, MD, 53-66Google Scholar
  95. 95.
    McConnell JD, Barry MJ, Bruskewitz RC et al. (1994) Treatment preference analysis benign prostatic hyperplasia: diagnosis and treatment. Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services, Rockville, MD, 135-140Google Scholar
  96. 96.
    McConnell JD, Bruskewitz R, Walsh P et al. (1998) The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group. N Engl J Med 338:557–563Google Scholar
  97. 97.
    McLoughlin J, Gill KP, Abel PD, Williams G (1990) Symptoms versus flow rates versus urodynamics in the selection of patients for prostatectomy. Br J Urol 66:303–305PubMedCrossRefGoogle Scholar
  98. 98.
    Mebust WK, Holtgrewe HL, Cockett ATK, Peters PC (1989) Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3885 patients. J Urol 141:243–247PubMedGoogle Scholar
  99. 99.
    Melchior J, Valk WL, Foret JD, Mebust WK (1974) Transurethral prostatectomy in the azotemic patient. J Urol 112:643–646PubMedGoogle Scholar
  100. 100.
    Meyhoff HH, Nordling J, Haid T (1984) Urodynamic evaluation of transurethral versus transvesical prostatectomy. A randomized study. Scand J Urol Nephrol 18:27–35CrossRefGoogle Scholar
  101. 101.
    Muschter R, de la Rosette JJ, Whitfield H, Pellerin JP, Madersbacher S, Gillatt D (1996) Initial human clinical experience with diode laser interstitial treatment of benign prostatic hyperplasia. Urology 48:223–228PubMedCrossRefGoogle Scholar
  102. 102.
    Narayan P, Tewari A, Fournier G, Toke A (1995) Impact of prostate size on the outcome of transurethral laser evaporation of the prostate for benign prostatic hyperplasia. Urology 45: 776–782PubMedCrossRefGoogle Scholar
  103. 103.
    Nawrocki JD, Bell TJ, Lawrence WT, Ward JP (1997) A randomized controlled trial of transurethral microwave thermotherapy. Br J Urol 79:389–393PubMedGoogle Scholar
  104. 104.
    Neal DE, Ramsden PD, Sharples L, Smith A, Powell PH, Styles RA, Webb RJ (1989) Outcome of elective prostatectomy. BMJ 299: 762–767PubMedCrossRefGoogle Scholar
  105. 105.
    Neal DE, Styles RA, Powell PH, Thong J, Ramsden PD (1987) Relationship between voiding pressures, symptoms and urodynamic findings in 253 men undergoing prostatectomy. Br J Urol 60: 554–559PubMedCrossRefGoogle Scholar
  106. 106.
    Netto Junior NR, de Lima ML, Claro JdA, de Andrade EF (1995) The importance of the prostate weight in transurethral microwave thermotherapy. Arch Esp Urol 48:413–417PubMedGoogle Scholar
  107. 107.
    Nitti VW, Kim Y, Combs AJ (1994) Correlation of the AUA symptom index with urodynamics in patients with suspected benign prostatic hyperplasia. Neurourol Urodyn 13:521–527PubMedCrossRefGoogle Scholar
  108. 108.
    Nitti VW, Kim Y, Combs AJ (1997) Voiding dysfunction following transurethral resection of the prostate: symptoms and urodynamic findings. J Urol 157:600–603PubMedCrossRefGoogle Scholar
  109. 109.
    Oelke M, Höfner K, Mebert J, Jonas U (1998) Sensitivity and specifity of uroflowmetry in patients with infravesical obstruction. 28th Annual Meeting International Continence Society Jerusalem. ICS 142Google Scholar
  110. 110.
    Patel A, Fuchs GJ, Gutierrez-Aceves J, Ryan TP (1997) Prostate heating patterns comparing electrosurgical transurethral resection and vaporization: a prospective randomized study. J Urol 157:169–172PubMedCrossRefGoogle Scholar
  111. 111.
    Poulsen AL, Schou J, Puggaard L, Torp Pedersen S, Nordling J (1994) Prostatic enlargement, symptomatology and pressure/flow evaluation: interrelations in patients with symptomatic BPH. Scand J Urol Nephrol 157 [Suppl]: 67–73.Google Scholar
  112. 112.
    Price DA, Ramsden PD, Stobbart D (1980) The unstable bladder and prostatectomy. Br J Urol 52: 529–531PubMedCrossRefGoogle Scholar
  113. 113.
    Riehmann M, Knes JM, Heisey D, Madsen PO, Bruskewitz RC (1995) Transurethral resection versus incision of the prostate: a randomized, prospective study. Urology 45: 768–775PubMedCrossRefGoogle Scholar
  114. 114.
    Roberts BJ, Lynch JH, Lau I, Wang JY, Lo S-CB, Mun SK, Hayes WS (1997) Transurethral microwave thermotherapy: prediction of treatment outcome using various analytical methods. J Urol 157 [Suppl]: 437.Google Scholar
  115. 115.
    Roehrborn CG (1998) Accurate determination of prostate size via digital rectal examination and transrectal ultrasound. Urology 51:19–22Google Scholar
  116. 116.
    Roehrborn CG, Girman CJ, Rhodes T et al. (1997) Correlation between prostate size estimated by digital rectal examination and measured by transrectal ultrasound. Urology 49:548–557PubMedCrossRefGoogle Scholar
  117. 117.
    Rollema HJ, van Mastrigt R (1992) Improved indication and followup in transurethral resection of the prostate using the Computer program CLIM: a prospective study. J Urol 148:111–115PubMedGoogle Scholar
  118. 118.
    Rollema HJ, van Mastrigt R, Janknegt RA (1991) Urodynamic assessment and quantification of prostatic obstruction before and after transurethral resection of the prostate: standardization with the aid of the Computer program CLIM. Urol Int 1: 52–54CrossRefGoogle Scholar
  119. 119.
    Rosier PF, de la Rosette JJ (1995) Is there a correlation between prostate size and bladder-outlet obstruction? World J Urol 13: 9–13PubMedCrossRefGoogle Scholar
  120. 120.
    Schäfer W, Rübben H, Noppeney R, Deutz F-J (1989) Obstructed and unobstructed prostatic obstruction. A plea for urodynamic objectivation for bladder outflow obstruction in benign prostatic hyperplasia. World J Urol 6:198–203CrossRefGoogle Scholar
  121. 121.
    Shokeir AA, al-Sisi H, Farage YM, el-Maaboud MA, Saeed M, Mutabagani H (1997) Transurethral prostatectomy: a prospective randomized study of conventional resection and electrovaporization in benign prostatic hyperplasia. Br J Urol 80: 570–574PubMedGoogle Scholar
  122. 122.
    Sparwasser C, Riehmann M, Knes J, Madsen PO (1995) Long-term results of transurethral prostate incision (TUIP) and transurethral prostate resection (TURP). A prospective randomized study. Urologe A 34:153–157Google Scholar
  123. 123.
    Speakman MJ, Sethia KK, Fellows GJ, Smith JC (1987) A study of the pathogenesis, urodynamic assessment and outcome of detrusor instability associated with bladder outflow obstruction. Brit J Urol 59: 40–44PubMedCrossRefGoogle Scholar
  124. 124.
    Stoner E (1994) Three-year safety and efficacy data on the use of finasteride in the treatment of benign prostatic hyperplasia. Urology 43: 284–292PubMedCrossRefGoogle Scholar
  125. 125.
    Styles RA, Ramsden PD, Neal DE (1991) The outcome of prostatectomy on chronic retention of urine. JUrol 146:1029–1033Google Scholar
  126. 126.
    Tammela TL, Kontturi MJ (1993) Urodynamic effects of finasteride in the treatment of bladder outlet obstruction due to benign prostatic hyperplasia. J Urol 149: 342–344PubMedGoogle Scholar
  127. 127.
    Tubaro A, Carter SS, de la Rosette J et al. (1995) The prediction of clinical outcome from transurethral microwave thermotherapy by pressure-flow analysis: a European multicenter study. J Urol 153: 1526–1530PubMedCrossRefGoogle Scholar
  128. 128.
    Uchida T, Egawa S, Iwamura M, Ohori M, Yokoyama E, Endo T, Koshiba K (1996) A non-randomized comparative study of visual laser ablation and transurethral resection of the prostate in benign prostatic hyperplasia. Int J Urol 3:108–112PubMedCrossRefGoogle Scholar
  129. 129.
    van de Beek C, Rollema HJ, van Mastrigt R, Janknegt RA (1992) Objective analysis of infravesical obstruction and detrusor contractility; appraisal of the Computer program Dx/CLIM and Schäfer nomogram. Neurourol Urodyn 1: 394–395Google Scholar
  130. 130.
    van Mastrigt R (1992) Age dependence of urinary bladder contractility. Neurourol Urodyn 1: 315–317Google Scholar
  131. 131.
    van Mastrigt R, Rollema HJ (1992) The prognostic value of bladder contractility in transurethral resection of the prostate. J Urol 148:1856–1860PubMedGoogle Scholar
  132. 132.
    van Venrooij GE, Boon TA, de Gier RP (1995) International prostate symptom score and quality of life assessment versus urodynamic parameters in men with benign prostatic hyperplasia symptoms. J Urol 153:1516–1519PubMedCrossRefGoogle Scholar
  133. 133.
    Watanabe H (1993) Diagnosis of benign prostatic hypertrophy by ultrasound and outcome from surgery. Akt Urol 24 [Suppl]: 127–130.Google Scholar
  134. 134.
    Witjes WP, Rosier FW, de Wildt MJ, van Iersel MP, Debruyne FM, de la Rosette JJ (1996) Urodynamic and clinical effects of terazosin therapy in patients with symptomatic benign prostatic hyperplasia. J Urol 155:1117–1123CrossRefGoogle Scholar
  135. 135.
    Yalla SV, Sullivan MP, Lecamwasam HS, DuBeau CE, Vickers MA, Cravalho EG (1995) Correlation of American Urological Association symptom index with obstructive and nonobstructive prostatism. J Urol 153: 674–679.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2000

Authors and Affiliations

  • K. Höfner

There are no affiliations available

Personalised recommendations